Currently, there are 163.55M common shares owned by the public and among those 139.69M shares have been available to trade.
The company’s stock has a 5-day price change of 19.30% and 42.26% over the past three months. PCT shares are trading 77.04% year to date (YTD), with the 12-month market performance down to -32.99% lower. It has a 12-month low price of $2.38 and touched a high of $11.89 over the same period. PCT has an average intraday trading volume of 1.62 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 24.48%, 28.55%, and 46.60% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of PureCycle Technologies Inc (NASDAQ: PCT) shares accounts for 80.39% of the company’s 163.55M shares outstanding.
It has a market capitalization of $1.18B and a beta (3y monthly) value of 1.67. The earnings-per-share (ttm) stands at -$1.01. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.35% over the week and 6.16% over the month.
Earnings per share for the fiscal year are expected to decrease by -50.37%, and 71.30% over the next financial year.
Looking at the support for the PCT, a number of firms have released research notes about the stock. Craig Hallum stated their Hold rating for the stock in a research note on January 03, 2024, with the firm’s price target at $4. ROTH MKM coverage for the PureCycle Technologies Inc (PCT) stock in a research note released on December 19, 2023 offered a Neutral rating with a price target of $3. Oppenheimer was of a view on November 09, 2023 that the stock is Perform, while Stifel gave the stock Buy rating on September 16, 2022, issuing a price target of $15. Cowen on their part issued Outperform rating on September 23, 2021.
